Seoul, South Korea

Cheol Ryong Ku

USPTO Granted Patents = 1 

Average Co-Inventor Count = 13.0

ph-index = 1


Company Filing History:


Years Active: 2022

Loading Chart...
1 patent (USPTO):Explore Patents

Title: **Innovative Contributions of Cheol Ryong Ku in Biopharmaceuticals**

Introduction

Cheol Ryong Ku, a prominent inventor based in Seoul, South Korea, has made significant strides in the field of biopharmaceuticals. With his extensive knowledge and expertise, he has developed innovations that address critical health issues, specifically related to thyroid diseases.

Latest Patents

Ku holds a patent for a fusion protein that comprises variants of the thyrotropin receptor (TSHR). This invention is pivotal, as it includes a fusion protein comprising an extracellular domain of a wild-type TSHR with specific amino acid substitutions. The fusion protein exhibits enhanced pharmaceutical efficacy, improved in-vivo persistence, and better protein stability. Furthermore, it has potential applications as a therapeutic agent or diagnostic reagent for conditions such as Graves' disease and Graves' ophthalmopathy.

Career Highlights

Throughout his career, Cheol Ryong Ku has collaborated with notable organizations in the industry. He has worked with Yuhan Corporation, a leading biopharmaceutical company, where he contributed to groundbreaking research and innovation. Additionally, his association with the Industry-Academic Cooperation Foundation at Yonsei University showcases his commitment to bridging the gap between academia and industry in the field of biopharmaceutical research.

Collaborations

Ku has worked alongside esteemed colleagues, such as Moo Young Song and Taejin Yoon, to innovate and advance therapeutic solutions in the medical field. Their collaborative efforts have been integral in the development and refinement of his patent, leading to improved treatments for thyroid-related diseases.

Conclusion

Cheol Ryong Ku's work exemplifies the vital role of inventors in the advancement of medical science. His patented fusion protein is a testament to his innovative spirit and dedication to improving patient outcomes. As he continues to explore new avenues in biopharmaceutical research, his contributions will undoubtedly pave the way for future breakthroughs in the industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…